What are the clinical features of immunodeficiencies?
You get recurrent infections (normal: <6-8 URI/year for the 1st 10 years; 6 otitis media and 2 gastroenteritis/year for the 1st 2-3 years), severe infections, from unusual pathogens (Aspergillus, Pneumocystis), at unusual sites (liver abscess, osteomyelitis).
The infections are from pathogens that would not normally cause disease in the individual, but because their immune system is compromised they contract them.
It could also be in unusual sites.
What are some warning signs of PID (primary immunodeficiency)?
The symptoms are not very clear cut, so clinicians use this list of symptoms if they suspect that a patient has PID.
Generically, describe primary immunodeficiencies.
They are usually genetic.
They are infrequent but can be life-threatening.
The adaptive immune system is made up of T and B cells.
The innate immune system is made up of phagocytes, complement, etc.
Frequency: 50% antibody 30% T cell 18% phagocytes 2% complement
List some defects that can occur in adaptive immunity.
List some major B lymphocyte disorders.
Describe X-linked Agammaglobulinaemia.
it is known as Bruton’s disease.
There is a defect in the gene that encodes a protein, Bruton’s tyrosine kinase, that is important in the development of B-lymphocytes.
The B-cells then cannot produce antibodies, and the patient will have recurrent severe bacterial infections.
It starts presenting during the 2nd half of first year of life (lung, ears, GI) – not in first half because still has maternal antibodies (IgG, then IgA via breastfeeding).
Describe the mechanism by which the Btk gene normally works, and what happens when it is defective.
It is the pre-B cell that expresses the Btk in a healthy scenario. It is downstream of the pre-B cell receptor that the pre-B cells express during this maturation stage, after they rearrange their genes.
If there is recognition of self-antigen, the receptor sends a signal via this Btk, which will rescue the cell from default apoptosis.
How would you investigate and treat X-linked Agammaglobulinaemia?
Investigations:
Treatment:
Give an example of a combined immunodeficiency.
Severe Combined ImmunoDeficiency (SCID)
Describe SCID and how it presents.
Presentation:
How would you investigate SCID?
How would you treat SCID?
What would be the outcome of SCID?
List some major T Lymphocyte disorders.
Describe DiGeorge Syndrome.
It is thymic hypoplasia.
There is a 22q11 deletion, so we get failure of developmental 3+4th pharyngeal pouches.
It leads to:
Describe Wiskott-Aldrich syndrome (WAS).
Describe Ataxia-Telengiectasia (AT).
Symptoms:
What are the two types of defects in innate immunity?
- complement defects
Describe phagocyte defects, and give some examples.
They can be quantitative (where you get a ↓ in number), or qualitative (where we get a decrease in quality).
Examples would be:
Describe Chronic Granulomatous Disease.
The defect is in the killing of the microbe, and it is to do with the generation of the oxidative species that are critical for the killing of certain pathogens.
This comes about as a mutation of the phagocyte oxidase (NADPH) components.
They can’t eliminate the pathogen, so the body form granulomas to try to prevent the spread of the infection to the rest of the body.
Describe the oxygen-dependent killing of pathogens.
After the microbe is taken up by the phagocyte, then you have the assembly of the NADPH complex by recruitment of subunits from the cytosol. This converts oxygen into the superoxide anion that can be used to generate the reactive oxygen species.
In the chronic granulomatous disease, there are defects in various components that lead to the formation of the complex, so it cannot create the superoxide anion, so it cannot generate reactive oxygen species.
How would you diagnose CGD?
You would use tests that measure oxidative burst:
Describe the NBT reduction test.
You take neutrophils (from the patient and control) and incubate them with the nitroblue tetrazolium reduction, then activate them using cytokines or microbes to see if they can produce reactive oxygen species.
If they can, they will cleave the dye, generating the blue colour. If they can’t, we won’t see the blue colour.
Describe the dihydrorhodamine assay.
Again, you will take neutrophils from the patient and control and activate them. If they can make reactive oxygen species, they will cleave the dihydrorhodamine and make it fluorescent If they can’t, it will remain dull.